Biohaven Ltd. (BHVN)
NYSE: BHVN · Real-Time Price · USD
15.23
+0.17 (1.13%)
At close: Aug 7, 2025, 4:00 PM
15.29
+0.06 (0.39%)
After-hours: Aug 7, 2025, 7:35 PM EDT
Biohaven Market Cap
Biohaven has a market cap or net worth of $1.56 billion as of August 7, 2025. Its market cap has decreased by -51.68% in one year.
Market Cap
1.56B
Enterprise Value
1.27B
1-Year Change
-51.68%
Ranking
Category
Stock Price
$15.23
Market Cap Chart
Since October 18, 2022, Biohaven's market cap has increased from $412.66M to $1.56B, an increase of 276.87%. That is a compound annual growth rate of 60.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2025 | 1.54B | -59.28% |
| Dec 31, 2024 | 3.78B | 9.99% |
| Dec 29, 2023 | 3.43B | 262.97% |
| Dec 30, 2022 | 946.07M | 129.26% |
| Oct 18, 2022 | 412.66M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 680.89B |
| Johnson & Johnson | 409.10B |
| AbbVie | 345.75B |
| AstraZeneca | 231.42B |
| Novartis AG | 228.98B |
| UnitedHealth Group | 228.68B |
| Abbott Laboratories | 226.88B |
| Novo Nordisk | 210.71B |